Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT05870540

1 development in the corpus

NCT05870540

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 2 TRIAL

BPL-003 Efficacy and Safety in Treatment Resistant Depression

ClinicalTrials.gov

Phase 2 trial with planned enrollment of 196 participants studying a novel psychiatric drug; results not yet reported in this registry record.

PreliminaryTreatment Resistant Depression BPL-003 Beckley Psytech

Reported

Sample size196

PhasePhase 2

Primary efficacy endpointChange from baseline in MADRS total score a…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support